Original Article Epidemiology Diabetes Metab J 2013;37:433-449 http://dx.doi.org/10.4093/dmj.2013.37.6.433 pISSN 2233-6079 · eISSN 2233-6087
DIABETES & METABOLISM JOURNAL
Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010 Eun Roh1, Seung-Hyun Ko2, Hyuk-Sang Kwon2, Nan Hee Kim3, Jae Hyeon Kim4, Chul Sik Kim5, Kee-Ho Song6, Jong Chul Won7, Dae Jung Kim8, Sung Hee Choi1, Soo Lim1, Bong-Yun Cha2, on behalf of the Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, 3 Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, 4 Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 5 Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, 6 Department of Internal Medicine, Konkuk University School of Medicine, Seoul, 7 Department of Internal Medicine, Mitochondrial Research Group, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, 8 Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea 1 2
Background: Dyslipidemia is a major risk factor of cardiovascular disease. The aim of this study was to investigate the changing trends in the prevalence and management status of dyslipidemia among Korean adults. Methods: The prevalence of dyslipidemia and the rates of awareness, treatment, and control of dyslipidemia were investigated in adults aged ≥20 years from the Korea National Health and Nutrition Surveys (KNHANES) 1998 to 2010. The updated National Cholesterol Education Program criteria was used, which define dyslipidemia as having one or more of the following lipid abnormalities: hypercholesterolemia (total cholesterol ≥240 mg/dL or diagnosis of dyslipidemia or use of lipid-lowering drugs), hypertriglyceridemia (≥150 mg/dL), hyper-low density lipoprotein (LDL) cholesterolemia (≥160 mg/dL or diagnosis of dyslipidemia or use of lipid-lowering drugs), and hypo-high density lipoprotein (HDL)-cholesterolemia (
DIABETES & METABOLISM JOURNAL
Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010 Eun Roh1, Seung-Hyun Ko2, Hyuk-Sang Kwon2, Nan Hee Kim3, Jae Hyeon Kim4, Chul Sik Kim5, Kee-Ho Song6, Jong Chul Won7, Dae Jung Kim8, Sung Hee Choi1, Soo Lim1, Bong-Yun Cha2, on behalf of the Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, 3 Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, 4 Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 5 Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, 6 Department of Internal Medicine, Konkuk University School of Medicine, Seoul, 7 Department of Internal Medicine, Mitochondrial Research Group, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, 8 Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea 1 2
Background: Dyslipidemia is a major risk factor of cardiovascular disease. The aim of this study was to investigate the changing trends in the prevalence and management status of dyslipidemia among Korean adults. Methods: The prevalence of dyslipidemia and the rates of awareness, treatment, and control of dyslipidemia were investigated in adults aged ≥20 years from the Korea National Health and Nutrition Surveys (KNHANES) 1998 to 2010. The updated National Cholesterol Education Program criteria was used, which define dyslipidemia as having one or more of the following lipid abnormalities: hypercholesterolemia (total cholesterol ≥240 mg/dL or diagnosis of dyslipidemia or use of lipid-lowering drugs), hypertriglyceridemia (≥150 mg/dL), hyper-low density lipoprotein (LDL) cholesterolemia (≥160 mg/dL or diagnosis of dyslipidemia or use of lipid-lowering drugs), and hypo-high density lipoprotein (HDL)-cholesterolemia (
